These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21576426)

  • 1. Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.
    Ramón-García S; Ng C; Anderson H; Chao JD; Zheng X; Pfeifer T; Av-Gay Y; Roberge M; Thompson CJ
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3861-9. PubMed ID: 21576426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.
    Tanner L; Mashabela GT; Omollo CC; de Wet TJ; Parkinson CJ; Warner DF; Haynes RK; Wiesner L
    Microbiol Spectr; 2021 Oct; 9(2):e0043421. PubMed ID: 34585951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
    Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
    Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.
    Ma S; Jaipalli S; Larkins-Ford J; Lohmiller J; Aldridge BB; Sherman DR; Chandrasekaran S
    mBio; 2019 Nov; 10(6):. PubMed ID: 31719182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics.
    Bruhn DF; Scherman MS; Liu J; Scherbakov D; Meibohm B; Böttger EC; Lenaerts AJ; Lee RE
    Sci Rep; 2015 Sep; 5():13985. PubMed ID: 26365087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model.
    Silva A; Lee BY; Clemens DL; Kee T; Ding X; Ho CM; Horwitz MA
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2172-9. PubMed ID: 27035987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.
    Bassett IM; Lun S; Bishai WR; Guo H; Kirman JR; Altaf M; O'Toole RF
    J Microbiol; 2013 Oct; 51(5):651-8. PubMed ID: 23800952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
    Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
    J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy.
    Pieroni M; Machado D; Azzali E; Santos Costa S; Couto I; Costantino G; Viveiros M
    J Med Chem; 2015 Aug; 58(15):5842-53. PubMed ID: 26197353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
    Dixit PP; Dixit PP; Thore SN
    Eur J Med Chem; 2016 Jan; 107():38-47. PubMed ID: 26562541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial Activity of combinatorial treatments composed of transition-metal/antibiotics against Mycobacterium tuberculosis.
    Montelongo-Peralta LZ; León-Buitimea A; Palma-Nicolás JP; Gonzalez-Christen J; Morones-Ramírez JR
    Sci Rep; 2019 Apr; 9(1):5471. PubMed ID: 30940878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loperamide exerts a direct bactericidal effect against M. tuberculosis, M. bovis, M. terrae and M. smegmatis.
    Barrientos OM; Juárez E; Gonzalez Y; Castro-Villeda DA; Torres M; Guzmán-Beltrán S
    Lett Appl Microbiol; 2021 Mar; 72(3):351-356. PubMed ID: 33220096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore.
    Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS
    Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Small-Molecule Inhibitor of the
    Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
    mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
    Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
    J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.